CD300C
Summary: The CMRF35 antigen, which was identified by reactivity with a monoclonal antibody, is present on monocytes, neutrophils, and some T and B lymphocytes (Jackson et al., 1992 [PubMed 1349532]).[supplied by OMIM, Mar 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
CD300c molecule | MIM:606786 | Ensembl:ENSG00000167850 | HGNC:HGNC:19320 | PA142672150 | 17q25.1 |
Gene Categories:
DRUGGABLE GENOMEGO terms in CD300C
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | TAS | GO:0004888 | transmembrane signaling receptor activity |
BP | IEA | GO:0002376 | immune system process |
BP | TAS | GO:0006968 | cellular defense response |
BP | IEA | GO:0007165 | signal transduction |
BP | TAS | GO:0050776 | regulation of immune response |
CC | TAS | GO:0005886 | plasma membrane |
CC | TAS | GO:0005887 | integral component of plasma membrane |
Gene expression in normal tissue: CD300C
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CD300C
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1280218 | Adaptive Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CD300C